Search Books

Dynogen enters into irritable bowel syndrome agreement with Mitsubishi.(Dynogen Pharmaceuticals Inc., Mitsubishi Pharma Corp.): An article from: BIOTECH Patent News

Publisher Biotech Patent News
📄 Viewing lite version Full site ›
🌎 Shop on Amazon — choose country
5.95 USD
🛒 Buy New on Amazon 🇺🇸

✓ Available for download now

Share:
Book Details
ISBN / ASINB0008GE7GE
ISBN-13978B0008GE7G1
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸

Description

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on December 1, 2003. The length of the article is 558 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Dynogen enters into irritable bowel syndrome agreement with Mitsubishi.(Dynogen Pharmaceuticals Inc., Mitsubishi Pharma Corp.)
Publication:BIOTECH Patent News (Newsletter)
Date: December 1, 2003
Publisher: Biotech Patent News
Volume: 17 Issue: 12

Distributed by Thomson Gale